Vimarsana
Biggest News Aggregation in the World

Page 2 - Advrt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advrt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advrt Today - Breaking & Trending Today

Weibo's Hong Kong listing to raise $385 mln -sources - Vimarsana News

Weibo's Hong Kong listing to raise $385 mln -sources

Chinese social media firm Weibo Corp plans to price its shares at HK$272.8 ($35.01) each to raise $385 million in its Hong Kong secondary listing, said three sources with direct knowledge of the matter.

EU rules aim for more transparency in targeted political ads - Vimarsana News

EU rules aim for more transparency in targeted political ads

U.S. tech giants will have to provide more data on their targeted political ads or risk fines up to 4% of their global turnover under draft EU rules seen by Reuters, part of the bloc's crackdown on misinformation during elections.

Russia's Sberbank, Mail.Ru invest extra $168 mln into JV - Vimarsana News

Russia's Sberbank, Mail.Ru invest extra $168 mln into JV

Russia's largest lender Sberbank and internet firm Mail.Ru have invested an additional 12.2 billion roubles ($168.39 million) in their ride-hailing and food delivery joint venture, the companies said on Thursday.

Man accused of mowing down Canadian Muslim family appears in court - Vimarsana News

Man accused of mowing down Canadian Muslim family appears in court

The man accused of mowing down a Muslim family with his pickup truck in what Canadian police are calling a hate-motivated attack appeared briefly by Zoom before a judge on Thursday and is due back early next week.

Canada panel says COVID-19 shots can be mixed, cases fall steadily - Vimarsana News

Canada panel says COVID-19 shots can be mixed, cases fall steadily

An official Canadian panel on Tuesday said people who received a first shot of AstraZeneca PLC's (AZN.L) COVID-19 vaccine can choose to receive a different shot for their second dose, dealing another potential blow to the pharmaceutical giant.